HEADER SIGNALING PROTEIN 12-NOV-18 6I4X TITLE CRYSTAL STRUCTURE OF SOCS2:ELONGIN C:ELONGIN B IN COMPLEX WITH TITLE 2 ERYTHROPOIETIN RECEPTOR PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGIN-B; COMPND 3 CHAIN: B; COMPND 4 SYNONYM: ELOB,ELONGIN 18 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 5 FACTOR SIII SUBUNIT B,SIII P18,TRANSCRIPTION ELONGATION FACTOR B COMPND 6 POLYPEPTIDE 2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ELONGIN-C; COMPND 10 CHAIN: C; COMPND 11 SYNONYM: ELOC,ELONGIN 15 KDA SUBUNIT,RNA POLYMERASE II TRANSCRIPTION COMPND 12 FACTOR SIII SUBUNIT C,SIII P15,TRANSCRIPTION ELONGATION FACTOR B COMPND 13 POLYPEPTIDE 1; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: SUPPRESSOR OF CYTOKINE SIGNALING 2; COMPND 17 CHAIN: A; COMPND 18 SYNONYM: SOCS-2,CYTOKINE-INDUCIBLE SH2 PROTEIN 2,CIS-2,STAT-INDUCED COMPND 19 STAT INHIBITOR 2,SSI-2; COMPND 20 ENGINEERED: YES; COMPND 21 MOL_ID: 4; COMPND 22 MOLECULE: ERYTHROPOIETIN RECEPTOR; COMPND 23 CHAIN: D; COMPND 24 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ELOB, TCEB2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ELOC, TCEB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: SOCS2, CIS2, SSI2, STATI2; SOURCE 20 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 21 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 22 MOL_ID: 4; SOURCE 23 SYNTHETIC: YES; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606 KEYWDS COMPLEX, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR W.W.KUNG,S.RAMACHANDRAN,N.MAKUKHIN,E.BRUNO,A.CIULLI REVDAT 3 19-JUN-19 6I4X 1 JRNL REVDAT 2 12-JUN-19 6I4X 1 TITLE AUTHOR REVDAT 1 29-MAY-19 6I4X 0 JRNL AUTH W.W.KUNG,S.RAMACHANDRAN,N.MAKUKHIN,E.BRUNO,A.CIULLI JRNL TITL STRUCTURAL INSIGHTS INTO SUBSTRATE RECOGNITION BY THE SOCS2 JRNL TITL 2 E3 UBIQUITIN LIGASE. JRNL REF NAT COMMUN V. 10 2534 2019 JRNL REFN ESSN 2041-1723 JRNL PMID 31182716 JRNL DOI 10.1038/S41467-019-10190-4 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.36 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 12266 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.220 REMARK 3 FREE R VALUE TEST SET COUNT : 640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.3629 - 4.5918 0.98 2509 137 0.1691 0.1961 REMARK 3 2 4.5918 - 3.6468 0.99 2484 144 0.1684 0.2189 REMARK 3 3 3.6468 - 3.1865 0.99 2433 143 0.2071 0.2338 REMARK 3 4 3.1865 - 2.8954 0.98 2449 137 0.2633 0.3064 REMARK 3 5 2.8954 - 2.6880 0.70 1751 79 0.2950 0.4004 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 2828 REMARK 3 ANGLE : 0.451 3834 REMARK 3 CHIRALITY : 0.038 445 REMARK 3 PLANARITY : 0.003 480 REMARK 3 DIHEDRAL : 8.504 1710 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6I4X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200012787. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9686 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12273 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.690 REMARK 200 RESOLUTION RANGE LOW (A) : 29.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.10800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.82 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CACODYLATE, ETHANOL, HEPES, REMARK 280 MAGNESIUM CHLORIDE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 17.92818 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.16350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 101.65974 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 17.92818 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.16350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 101.65974 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 308 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS B 104 REMARK 465 MET C 16 REMARK 465 SER C 47 REMARK 465 GLY C 48 REMARK 465 PRO C 49 REMARK 465 GLY C 50 REMARK 465 GLN C 51 REMARK 465 PHE C 52 REMARK 465 ALA C 53 REMARK 465 GLU C 54 REMARK 465 ASN C 55 REMARK 465 GLU C 56 REMARK 465 ARG A 137 REMARK 465 THR A 138 REMARK 465 GLY A 139 REMARK 465 PRO A 140 REMARK 465 GLU A 141 REMARK 465 ALA A 142 REMARK 465 PRO A 143 REMARK 465 ARG A 144 REMARK 465 ASN A 145 REMARK 465 GLY A 146 REMARK 465 THR A 147 REMARK 465 ALA D -4 REMARK 465 SER D 6 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 29 NE CZ NH1 NH2 REMARK 470 GLN B 65 CG CD OE1 NE2 REMARK 470 ASP B 82 CG OD1 OD2 REMARK 470 ASP B 83 CG OD1 OD2 REMARK 470 THR B 84 OG1 CG2 REMARK 470 GLU B 98 CG CD OE1 OE2 REMARK 470 ASP B 101 CG OD1 OD2 REMARK 470 THR C 57 OG1 CG2 REMARK 470 ASN C 58 CG OD1 ND2 REMARK 470 GLU C 59 CG CD OE1 OE2 REMARK 470 ARG C 63 CG CD NE CZ NH1 NH2 REMARK 470 THR C 84 OG1 CG2 REMARK 470 ASN C 85 CG OD1 ND2 REMARK 470 SER C 86 OG REMARK 470 SER C 87 OG REMARK 470 SER A 30 OG REMARK 470 ARG A 41 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 63 CG CD CE NZ REMARK 470 GLN A 100 CG CD OE1 NE2 REMARK 470 ILE A 110 CG1 CG2 CD1 REMARK 470 CYS A 111 SG REMARK 470 LYS A 113 CG CD CE NZ REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 VAL A 148 CG1 CG2 REMARK 470 HIS A 149 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 154 CE NZ REMARK 470 GLU D -1 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS B 10 -117.62 52.80 REMARK 500 ASP B 47 -110.43 55.74 REMARK 500 ALA B 71 81.39 -156.57 REMARK 500 ASP B 82 -109.04 58.98 REMARK 500 LEU C 37 0.29 -69.84 REMARK 500 TYR C 83 57.01 -107.50 REMARK 500 ASP C 111 74.73 56.71 REMARK 500 SER A 52 46.12 -83.88 REMARK 500 ILE A 110 89.04 -64.36 REMARK 500 CYS A 111 -6.59 71.77 REMARK 500 ASP A 135 -73.58 -60.10 REMARK 500 THR A 153 -88.96 -122.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C9W RELATED DB: PDB REMARK 900 2C9W CONTAINS THE SAME PROTEIN COMPLEX SOCS2-ELOB-ELOC DBREF 6I4X B 1 104 UNP Q15370 ELOB_HUMAN 1 104 DBREF 6I4X C 17 112 UNP Q15369 ELOC_HUMAN 17 112 DBREF 6I4X A 30 198 UNP O14508 SOCS2_HUMAN 30 198 DBREF 6I4X D -4 6 PDB 6I4X 6I4X -4 6 SEQADV 6I4X MET C 16 UNP Q15369 INITIATING METHIONINE SEQADV 6I4X MET A 31 UNP O14508 PRO 31 CONFLICT SEQADV 6I4X ALA A 115 UNP O14508 LYS 115 CONFLICT SEQADV 6I4X ALA A 117 UNP O14508 LYS 117 CONFLICT SEQADV 6I4X ALA A 118 UNP O14508 GLN 118 CONFLICT SEQRES 1 B 104 MET ASP VAL PHE LEU MET ILE ARG ARG HIS LYS THR THR SEQRES 2 B 104 ILE PHE THR ASP ALA LYS GLU SER SER THR VAL PHE GLU SEQRES 3 B 104 LEU LYS ARG ILE VAL GLU GLY ILE LEU LYS ARG PRO PRO SEQRES 4 B 104 ASP GLU GLN ARG LEU TYR LYS ASP ASP GLN LEU LEU ASP SEQRES 5 B 104 ASP GLY LYS THR LEU GLY GLU CYS GLY PHE THR SER GLN SEQRES 6 B 104 THR ALA ARG PRO GLN ALA PRO ALA THR VAL GLY LEU ALA SEQRES 7 B 104 PHE ARG ALA ASP ASP THR PHE GLU ALA LEU CAS ILE GLU SEQRES 8 B 104 PRO PHE SER SER PRO PRO GLU LEU PRO ASP VAL MET LYS SEQRES 1 C 97 MET MET TYR VAL LYS LEU ILE SER SER ASP GLY HIS GLU SEQRES 2 C 97 PHE ILE VAL LYS ARG GLU HIS ALA LEU THR SER GLY THR SEQRES 3 C 97 ILE LYS ALA MET LEU SER GLY PRO GLY GLN PHE ALA GLU SEQRES 4 C 97 ASN GLU THR ASN GLU VAL ASN PHE ARG GLU ILE PRO SER SEQRES 5 C 97 HIS VAL LEU SER LYS VAL CYS MET TYR PHE THR TYR LYS SEQRES 6 C 97 VAL ARG TYR THR ASN SER SER THR GLU ILE PRO GLU PHE SEQRES 7 C 97 PRO ILE ALA PRO GLU ILE ALA LEU GLU LEU LEU MET ALA SEQRES 8 C 97 ALA ASN PHE LEU ASP CYS SEQRES 1 A 169 SER MET GLN ALA ALA ARG LEU ALA LYS ALA LEU ARG GLU SEQRES 2 A 169 LEU GLY GLN THR GLY TRP TYR TRP GLY SER MET THR VAL SEQRES 3 A 169 ASN GLU ALA LYS GLU LYS LEU LYS GLU ALA PRO GLU GLY SEQRES 4 A 169 THR PHE LEU ILE ARG ASP SER SER HIS SER ASP TYR LEU SEQRES 5 A 169 LEU THR ILE SER VAL LYS THR SER ALA GLY PRO THR ASN SEQRES 6 A 169 LEU ARG ILE GLU TYR GLN ASP GLY LYS PHE ARG LEU ASP SEQRES 7 A 169 SER ILE ILE CYS VAL LYS SER ALA LEU ALA ALA PHE ASP SEQRES 8 A 169 SER VAL VAL HIS LEU ILE ASP TYR TYR VAL GLN MET CAS SEQRES 9 A 169 LYS ASP LYS ARG THR GLY PRO GLU ALA PRO ARG ASN GLY SEQRES 10 A 169 THR VAL HIS LEU TYR LEU THR LYS PRO LEU TYR THR SER SEQRES 11 A 169 ALA PRO SER LEU GLN HIS LEU CYS ARG LEU THR ILE ASN SEQRES 12 A 169 LYS CYS THR GLY ALA ILE TRP GLY LEU PRO LEU PRO THR SEQRES 13 A 169 ARG LEU LYS ASP TYR LEU GLU GLU TYR LYS PHE GLN VAL SEQRES 1 D 11 ALA SER PHE GLU PTR THR ILE LEU ASP PRO SER MODRES 6I4X CAS B 89 CYS MODIFIED RESIDUE MODRES 6I4X CAS A 133 CYS MODIFIED RESIDUE HET CAS B 89 9 HET CAS A 133 9 HET PTR D 0 16 HET PEG A 201 7 HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETNAM PTR O-PHOSPHOTYROSINE HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 CAS 2(C5 H12 AS N O2 S) FORMUL 4 PTR C9 H12 N O6 P FORMUL 5 PEG C4 H10 O3 FORMUL 6 HOH *11(H2 O) HELIX 1 AA1 THR B 23 LYS B 36 1 14 HELIX 2 AA2 PRO B 38 ASP B 40 5 3 HELIX 3 AA3 ARG C 33 LEU C 37 1 5 HELIX 4 AA4 SER C 39 MET C 45 1 7 HELIX 5 AA5 PRO C 66 TYR C 83 1 18 HELIX 6 AA6 ALA C 96 ASP C 111 1 16 HELIX 7 AA7 MET A 31 GLY A 47 1 17 HELIX 8 AA8 THR A 54 LEU A 62 1 9 HELIX 9 AA9 SER A 121 CAS A 133 1 13 HELIX 10 AB1 SER A 162 LYS A 173 1 12 HELIX 11 AB2 PRO A 184 GLU A 193 1 10 SHEET 1 AA1 4 GLN B 49 LEU B 50 0 SHEET 2 AA1 4 GLN B 42 LYS B 46 -1 N LYS B 46 O GLN B 49 SHEET 3 AA1 4 ALA B 73 ALA B 81 -1 O GLY B 76 N TYR B 45 SHEET 4 AA1 4 THR B 84 PHE B 85 -1 O THR B 84 N ALA B 81 SHEET 1 AA2 8 GLN B 49 LEU B 50 0 SHEET 2 AA2 8 GLN B 42 LYS B 46 -1 N LYS B 46 O GLN B 49 SHEET 3 AA2 8 ALA B 73 ALA B 81 -1 O GLY B 76 N TYR B 45 SHEET 4 AA2 8 ASP B 2 ARG B 9 1 N MET B 6 O VAL B 75 SHEET 5 AA2 8 THR B 12 LYS B 19 -1 O ALA B 18 N VAL B 3 SHEET 6 AA2 8 GLU C 28 LYS C 32 1 O ILE C 30 N THR B 13 SHEET 7 AA2 8 TYR C 18 ILE C 22 -1 N LEU C 21 O PHE C 29 SHEET 8 AA2 8 GLU C 59 ASN C 61 1 O VAL C 60 N ILE C 22 SHEET 1 AA3 4 PHE A 70 ASP A 74 0 SHEET 2 AA3 4 LEU A 82 THR A 88 -1 O THR A 83 N ARG A 73 SHEET 3 AA3 4 GLY A 91 GLN A 100 -1 O LEU A 95 N ILE A 84 SHEET 4 AA3 4 LYS A 103 LEU A 106 -1 O ARG A 105 N GLU A 98 LINK C LEU B 88 N CAS B 89 1555 1555 1.33 LINK C CAS B 89 N ILE B 90 1555 1555 1.33 LINK C MET A 132 N CAS A 133 1555 1555 1.33 LINK C CAS A 133 N LYS A 134 1555 1555 1.33 LINK C GLU D -1 N PTR D 0 1555 1555 1.33 LINK C PTR D 0 N THR D 1 1555 1555 1.33 SITE 1 AC1 7 TRP A 50 LYS A 61 THR A 158 SER C 86 SITE 2 AC1 7 SER C 87 THR C 88 GLU C 89 CRYST1 41.287 56.327 203.392 90.00 91.53 90.00 I 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024221 0.000000 0.000647 0.00000 SCALE2 0.000000 0.017753 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004918 0.00000